CASI Pharmaceuticals (CASIF) Non-Current Assets (2021 - 2026)
CASI Pharmaceuticals (CASIF) recorded Non-Current Assets of $11.04 million in Q2 2026, down 15.3% from $13.04 million a year earlier.
Powered by 
Analysis
CASI Pharmaceuticals (CASIF) Non-Current Assets (2021 - 2026) Analysis & Trends
At the end of FY2025, CASI Pharmaceuticals reported Non-Current Assets of $12.19 million, down 13.5% from FY2024.
- Annual Non-Current Assets has declined for four straight years, with a four-year compound annual growth rate of -36.8% (FY2021 to FY2025).
- Across earlier years, Non-Current Assets came in at $14.1 million in FY2024 (-11.5%), $15.92 million in FY2023 (-30.2%), $22.81 million in FY2022 (-70.1%) and $76.33 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Non-Current Assets in data going back to Q4 2021.
- On a year-over-year basis, Non-Current Assets rose in 1 of the last seven quarters, with an average decline of 11.0%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 2.2% in Q3 2024, against a decline of 70.1% in Q4 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 159.99 Bn |
| 10 | CASI Pharmaceuticals | 2.06 Mn | -18.77 Mn | - | 11.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.04 Mn |
| Dec 31, 2025 | 12.19 Mn |
| Sep 30, 2025 | 12.55 Mn |
| Jun 30, 2025 | 13.04 Mn |
| Mar 31, 2025 | 13.66 Mn |
| Dec 31, 2024 | 14.10 Mn |
| Sep 30, 2024 | 16.46 Mn |
| Jun 30, 2024 | 14.08 Mn |
| Mar 31, 2024 | 14.86 Mn |
| Dec 31, 2023 | 15.92 Mn |
| Sep 30, 2023 | 16.11 Mn |
| Jun 30, 2023 | 16.87 Mn |
| Mar 31, 2023 | 21.80 Mn |
| Dec 31, 2022 | 22.81 Mn |
| Dec 31, 2021 | 76.33 Mn |
API Access
CASI Pharmaceuticals Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=CASIF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "CASIF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=CASIF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();